The FDA granted an orphan drug designation to PEP-010 for the treatment of patients with metastatic pancreatic cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback